Skip to content

Impact of Appointment Reminder Strategies on Smoking Cessation Clinic Attendance

Effect of Reminder Strategies on No-Show Rates in a Nicotine Cessation Clinic: A Randomized Controlled Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07779161
Acronym
NO-SHOW-NCC
Enrollment
300
Registered
2026-08-21
Start date
2026-08-01
Completion date
2027-04-01
Last updated
2026-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behavioral Intervention, Nicotine Addiction

Keywords

nicotine cessation clinic, nicotine, smoking cessation, clinic attendance, anti-nicotine clinic, adult smokers, behavioral intervention, patient engagement, reminder systems, healthcare attendance

Brief summary

The goal of this clinical trial is to learn whether different appointment reminder methods can improve attendance at an anti-smoking (smoking cessation) clinic among adult smokers. The main question it aims to answer is: "Which reminder method helps participants come to their scheduled smoking cessation clinic appointments most often?" Researchers will compare different appointment reminder methods with standard appointment scheduling to see if they help participants attend their clinic visits more often. Participants will: * Receive appointment reminders using different methods * Come to their scheduled visits at a smoking cessation (anti-nicotine) clinic

Interventions

BEHAVIORALStandard phone call

Participants will receive a phone call from a trained staff member 1-5 days before the appointment. The conversation will follow a strictly standardized script limited solely to confirming the appointment date, without any motivational or therapeutic elements.

BEHAVIORALphone call with MINDSPACE elements

Participants will receive a phone call 1-5 days before their appointment. The conversation will follow a standardized script incorporating behavioral intervention (nudging) elements based on the MINDSPACE framework. Key components of the script include: * Messenger (Sender): Emphasizing that the information comes from the medical team. * Norms (Social Norms): Referring to success statistics for regular visits. * Commitment: Encouraging verbal confirmation of attendance. * Affect (Emotions): Providing short messages reinforcing a sense of support.

Sponsors

Medical University of Gdansk
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years. Confirmed diagnosis of nicotine dependence (F17 according to the International Classification of Diseases, 10th Revision \[ICD-10\]) and active patient status at the Smoking Cessation Clinic. * Provision of voluntary, written, informed consent to participate in the study and to be contacted by telephone or short text message. * Ability to independently provide information and operate a mobile phone. * At the time of study enrollment, attendance at an initial visit at the clinic.

Exclusion criteria

* Age \< 18 years. * Lack of written, informed consent to participate in the study. * Inability to independently understand the study procedures or provide responses (e.g., due to dementia or a language barrier).

Design outcomes

Primary

MeasureTime frameDescription
Patient attendance at scheduled follow-up visitAt the second scheduled visit at the Nicotine Cessation Clinic (2-8 weeks after baseline).Primary Outcome: The primary outcome measure is a binary assessment of patient attendance (Present/Absent) at the scheduled second visit, which takes place 2-8 weeks after the initial visit, as determined by the physician's individual assessment. Attendance will be verified on the day of the scheduled visit based on objective data recorded in the "CliniNET" hospital system.

Secondary

MeasureTime frameDescription
Impact of sociodemographic and clinical factors on patient attendanceat baseline and 2 to 8 weeks after enrollmentSecondary Outcomes: Secondary analyses will include an assessment of the impact of sociodemographic and clinical factors based on tests routinely performed as part of a medical visit (age, sex, level of dependence according to the Fagerström Test for Nicotine Dependence (FTND)).

Countries

Poland

Contacts

CONTACTJagoda K Arendt
jagoda.arendt@gumed.edu.pl+48 509 388 251

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 22, 2026